Introduction There are some adverse reactions in a product label that are so serious, and possibly even preventable, that special labeling is required to highlight this warning information: a “BOXED WARNING.” https://www.fda.gov/media/71866/download https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=201.57 This boxed warning information, “critical for a prescriber to consider,” is commonly referred to as a […]
Report 63: In Q3 2022, Pfizer Wrote Off $450 Million of Expired or Expiring COVID-19-Related Inventory.
Despite generating over $100 billion in revenue in 2022, Pfizer’s stock has dropped precipitously. Pfizer’s revenue was relatively flat, hovering between $41 billion and $51 billion, from 2014 to 2020. Then, its mRNA COVID-19 “vaccine” was awarded Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) on December […]
Study Confirms that Molnupiravir Creates COVID “Variant Soup”. How could the FDA Approve It?
A couple of weeks ago, I made a post that alleged that Molnupiravir, a mutagenic drug that makes the RNA of Sars-Cov-2 mutate, causes new COVID variants to appear faster than before. A pre-print for a new scientific study was just published that confirms this contention. Before we consider this study, […]
Radio Interview: Dr. Flowers on the Use of Paxlovid Following mRNA Vaccination
In this interview segment, Dr. Flowers concentrates on the use of Paxlovid in patients with COVID following vaccination. Informed doctors who had taken the vaccines and boosters decided that there is no way they would use expensive Paxlovid for minimal symptoms commonly experienced with recurrent COVID.